Gray Nancy Ryan (CIK 1714949) reported 6 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-09). Recent activity: Buy LGND (836 shares), Buy LGND (3,015 shares), Buy LGND (3,556 shares), Sell LGND (3,556 shares), Sell LGND (3,015 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-09 | LIGAND PHARMACEUTICALS INC (LGND) | Director | Buy | 836 | $0 |
| 2025-11-12 | LIGAND PHARMACEUTICALS INC (LGND) | Director | Buy | 3,015 | $221,814 |
| 2025-11-12 | LIGAND PHARMACEUTICALS INC (LGND) | Director | Buy | 3,556 | $235,372 |
| 2025-11-12 | LIGAND PHARMACEUTICALS INC (LGND) | Director | Sell | 3,556 | $730,580 |
| 2025-11-12 | LIGAND PHARMACEUTICALS INC (LGND) | Director | Sell | 3,015 | $619,432 |
| 2025-06-10 | LIGAND PHARMACEUTICALS INC (LGND) | Director | Buy | 1,209 | $0 |
Source: SEC Form 4 filings · as of 2026-06-09